Role of myofiber-specific FoxP1 in pancreatic cancer-induced muscle wasting
American Journal of Physiology-Cell Physiology · 01.01.2025 · 328 (1) · C1-C8
DOI: 10.1152/ajpcell.00701.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.01.2025. Verfasst von Martin M Schonk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, United States. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Pancreatic Neoplasms, Cachexia, Repressor Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Cancer Institute (NCI), NIAMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Here we identify myofiber-derived FoxP1 as a negative regulator of skeletal muscle with sex-specific effects in cancer. Under cancer-free conditions, FoxP1 knockout increased myofiber size in male and female mice. However, in response to pancreatic cancer, FoxP1 myofiber-specific deletion attenuated muscle wasting and weakness in males but not females. This highlights the need to consider sexual dimorphism in cancer-induced muscle pathologies and provides evidence suggesting that targeting FoxP1 could help mitigate these effects in males.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Therapy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, United States.
- Myology Institute, University of Florida, Gainesville, Florida, United States.
- Department of Physiology and Aging, College of Medicine, University of Florida, Gainesville, Florida, United States.
- Department of Molecular Biosciences and the Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas, United States.
ORCID-Profile: Martin M Schonk, Jeremy B Ducharme, Sarah M Judge, Andrew R Judge
Förderung
- HHS | NIH | National Cancer Institute (NCI)
- NIAMS NIH HHS
- NCI NIH HHS
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Cancer Prevention and Research Institute of Texas (CPRIT)
Zitieren
APA
Schonk, M. M., Ducharme, J. B., Neyroud, D., Nosacka, R. L., Tucker, H. O., Judge, S. M., & Judge, A. R. (2025). Role of myofiber-specific FoxP1 in pancreatic cancer-induced muscle wasting. American Journal of Physiology-Cell Physiology, 328(1), C1-C8. https://doi.org/10.1152/ajpcell.00701.2024
Vancouver
Schonk MM, Ducharme JB, Neyroud D, Nosacka RL, Tucker HO, Judge SM, et al. Role of myofiber-specific FoxP1 in pancreatic cancer-induced muscle wasting. American Journal of Physiology-Cell Physiology. 2025;328(1):C1-C8. doi:10.1152/ajpcell.00701.2024
BibTeX
@article{Schonk2025,
author = {Schonk, Martin M and Ducharme, Jeremy B and Neyroud, Daria and Nosacka, Rachel L and Tucker, Haley O and Judge, Sarah M and Judge, Andrew R},
title = {Role of myofiber-specific FoxP1 in pancreatic cancer-induced muscle wasting},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
volume = {328},
number = {1},
pages = {C1--C8},
doi = {10.1152/ajpcell.00701.2024}
}
EUVIMED